1. Home
  2. CRC vs IOVA Comparison

CRC vs IOVA Comparison

Compare CRC & IOVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRC
  • IOVA
  • Stock Information
  • Founded
  • CRC 2014
  • IOVA 2007
  • Country
  • CRC United States
  • IOVA United States
  • Employees
  • CRC N/A
  • IOVA N/A
  • Industry
  • CRC Oil & Gas Production
  • IOVA Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • CRC Energy
  • IOVA Health Care
  • Exchange
  • CRC Nasdaq
  • IOVA Nasdaq
  • Market Cap
  • CRC 4.8B
  • IOVA 2.6B
  • IPO Year
  • CRC N/A
  • IOVA N/A
  • Fundamental
  • Price
  • CRC $53.91
  • IOVA $5.89
  • Analyst Decision
  • CRC Strong Buy
  • IOVA Strong Buy
  • Analyst Count
  • CRC 13
  • IOVA 9
  • Target Price
  • CRC $66.38
  • IOVA $23.33
  • AVG Volume (30 Days)
  • CRC 845.9K
  • IOVA 8.2M
  • Earning Date
  • CRC 02-25-2025
  • IOVA 02-26-2025
  • Dividend Yield
  • CRC 2.63%
  • IOVA N/A
  • EPS Growth
  • CRC 11.09
  • IOVA N/A
  • EPS
  • CRC 6.96
  • IOVA N/A
  • Revenue
  • CRC $2,592,000,000.00
  • IOVA $90,858,000.00
  • Revenue This Year
  • CRC $11.64
  • IOVA $13,758.71
  • Revenue Next Year
  • CRC $9.94
  • IOVA $171.20
  • P/E Ratio
  • CRC $7.63
  • IOVA N/A
  • Revenue Growth
  • CRC N/A
  • IOVA 12751.20
  • 52 Week Low
  • CRC $43.09
  • IOVA $5.77
  • 52 Week High
  • CRC $60.41
  • IOVA $18.33
  • Technical
  • Relative Strength Index (RSI)
  • CRC 54.09
  • IOVA 26.25
  • Support Level
  • CRC $51.50
  • IOVA $5.77
  • Resistance Level
  • CRC $53.52
  • IOVA $8.15
  • Average True Range (ATR)
  • CRC 1.53
  • IOVA 0.44
  • MACD
  • CRC 0.42
  • IOVA -0.11
  • Stochastic Oscillator
  • CRC 84.43
  • IOVA 5.04

About CRC California Resources Corporation

California Resources Corp is an independent oil and natural gas exploration and production company operating properties exclusively within California. It provides affordable and reliable energy in a safe and responsible manner, to support and enhance the quality of life of Californians and the local communities in which the company operates. It has some of the lowest carbon intensity production in the United States and is focused on maximizing the value of its land, mineral, and technical resources for decarbonization by developing carbon capture and storage (CCS) and other emissions-reducing projects.

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.

Share on Social Networks: